| Understanding context for adapting the New Medicine Service for Switzerland using a convergent mixed methods design – myCare Start-I | 9th PCNE Working Symposium 2024 | | | 2024 | 34 | 0 |
|
| Exposure to alirocumab during the first trimester of pregnancy: A case report | Birth defects research |  | | 2021 | 286 | 288 |
|
| Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study | Multiple Sclerosis Journal |  | | 2021 | 289 | 0 |
|
| Maternal Infection and Adverse Pregnancy Outcomes among Pregnant Travellers: Results of the International Zika Virus in Pregnancy Registry | Viruses | | | 2021 | 131 | 163 |
|
| A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk | British Journal of Clinical Pharmacology | | | 2020 | 452 | 2 |
|
| Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an update | Expert Opinion on Drug Safety | | | 2019 | 290 | 0 |
|
| Bon usage des antidépresseurs ISRS durant la grossesse – le défi de l'évaluation de la balance bénéfice-risque | Revue médicale suisse | | | 2016 | 701 | 5 |
|
